a public good project by the
Synthesis
Company
of California

© 2026

Tipu Nazeer | doi.page

0 works0 citations0 h-index

Tipu Nazeer

Albany Medical Center Hospital(US)

Publications by Year

Research Areas

Lymphoma Diagnosis and Treatment, Prostate Cancer Diagnosis and Treatment, Bladder and Urothelial Cancer Treatments, Prostate Cancer Treatment and Research, Urinary and Genital Oncology Studies

Most-Cited Works

→ Role of fluorine‐18 fluoro‐deoxyglucose positron emission tomography scan in the evaluation and follow‐up of patients with low‐grade lymphomas(2006)199 cited
→ Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy(2013)147 cited
→ A High Frequency of Activating Extracellular Domain ERBB2 ( HER2 ) Mutation in Micropapillary Urothelial Carcinoma(2013)136 cited
→ PROGNOSTIC SIGNIFICANCE OF HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA AND ATYPICAL SMALL ACINAR PROLIFERATION IN THE CONTEMPORARY ERA(2005)132 cited
→ Phase II Trial of Infusional Cyclophosphamide, Doxorubicin, and Etoposide in Patients With HIV-Associated Non-Hodgkin’s Lymphoma: An Eastern Cooperative Oncology Group Trial (E1494)(2004)121 cited
→ Role of prostate biopsy schemes in accurate prediction of Gleason scores(2006)115 cited

→ Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations(2015)104 cited

E-cadherin expression in prostatic carcinoma biopsies: correlation with tumor grade, DNA content, pathologic stage, and clinical outcome.(1994)

→ Contribution of HER‐2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis(1993)68 cited

Identification of HER-2/neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma.(1997)